Modifiable risk factors to reduce renal cell carcinoma incidence: Insight from the PLCO trial

Identify modifiable factors contributing to renal cell carcinoma in the PCLO to target disease prevention and reduce health care costs.

Source: Urologic Oncology: Seminars and Original Investigations - May 17, 2018 Category: Urology & Nephrology Authors: Jonathan Gelfond, Osamah Al-Bayati, Aashish Kabra, Kevan Iffrig, Dharam Kaushik, Michael A. Liss Tags: Original article Source Type: research